financetom
Business
financetom
/
Business
/
Microsoft Insider Sold Shares Worth $10,641,950, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Microsoft Insider Sold Shares Worth $10,641,950, According to a Recent SEC Filing
May 28, 2024 1:13 AM

03:47 AM EDT, 05/28/2024 (MT Newswires) -- Judson Althoff, Executive Vice President, Chief Commercial Officer, on May 23, 2024, sold 25,000 shares in Microsoft ( MSFT ) for $10,641,950. Following the Form 4 filing with the SEC, Althoff has control over a total of 104,949 shares of the company, with 104,949 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/789019/000106299324011261/xslF345X03/form4.xml

Price: 430.33, Change: +0.17, Percent Change: +0.04

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vista says MNC Capital's likely pressure may have prompted bidder to pull offer for unit
Vista says MNC Capital's likely pressure may have prompted bidder to pull offer for unit
Jun 17, 2024
June 17 (Reuters) - Vista Outdoor ( VSTO ) said on Monday that possible pressure from investment firm MNC Capital might have forced one of the bidders for the company's sporting products business to drop its $2 billion offer. MNC's allegations that the bidder violated certain contractual agreements may have restricted the party's ability to make an offer for the...
Japan Pharma Giant Takeda's Anti-Seizure Treatment Flunks In Two Late-Stage Studies
Japan Pharma Giant Takeda's Anti-Seizure Treatment Flunks In Two Late-Stage Studies
Jun 17, 2024
Monday, Takeda Pharmaceutical Co Ltd ( TAK ) announced topline data from its SKYLINE and SKYWAY Phase 3 studies of Soticlestat (TAK-935). SKYLINE (TAK-935-3001) study evaluated soticlestat plus standard of care versus placebo plus standard of care in patients with refractory Dravet syndrome. Soticlestat narrowly missed the primary endpoint of reduction from baseline in convulsive seizure frequency compared to placebo...
Solid Power Appoints Linda Heller as CFO
Solid Power Appoints Linda Heller as CFO
Jun 17, 2024
08:38 AM EDT, 06/17/2024 (MT Newswires) -- Solid Power ( SLDP ) said Monday that it has appointed Linda Heller to succeed Kevin Paprzycki as the company's Chief Financial Officer. Heller previously served as CFO of Swell Energy for about three years. The company also reaffirmed its 2024 guidance provided in Q1 2024. ...
Market Chatter: Stellantis Engineers Asked to Return to Office
Market Chatter: Stellantis Engineers Asked to Return to Office
Jun 17, 2024
08:36 AM EDT, 06/17/2024 (MT Newswires) -- Stellantis ( STLA ) engineers have been working onsite at least three days a week since January, Bloomberg reported Monday, citing the company's engineering and technology head, Ned Curic. When a new car is introduced, some engineers work at the office as many as six days, Curic was quoted as saying in an...
Copyright 2023-2026 - www.financetom.com All Rights Reserved